A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology
- David Scott Miller
- , John A. Blessing
- , Richard D. Drake
- , Robert Higgins
- , D. Scott McMeekin
- , Louis V. Puneky
- , Carolyn N. Krasner
Research output: Contribution to journal › Article › peer-review
35
Link opens in a new tab
Scopus
citations